Comparative Assessment of Tedizolid Tissue Penetration and Pharmacokinetic Profile Between Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
Phase of Trial: Phase I
Latest Information Update: 25 Apr 2017
At a glance
- Drugs Tedizolid (Primary)
- Indications Bacteraemia; Gram-positive infections; Nosocomial pneumonia; Skin and soft tissue infections; Wound infections
- Focus Therapeutic Use
- Acronyms TZD MicroD
- 25 Apr 2017 Results of pharmacokinetic data from diabetic patients with lower limb infection (n=6) presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases
- 23 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 23 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.